Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.119
Delayed Data
As of 3:59pm ET
 -0.0211 / -15.06%
Today’s Change
0.07
Today|||52-Week Range
0.70
-74.41%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$2.5M

Company Description

Interpace Diagnostics Group, Inc. engages in the development and commercialization molecular diagnostic tests principally focused on early detection of high potential progressors to cancer. It offers commercialized molecular tests which include PancraGen, ThyGenX, and ThyraMIR. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.

Contact Information

Interpace Diagnostics Group, Inc.
Morris Corporate Center 1 Building A
Parsippany New Jersey 07054
P:(844) 405-9655
Investor Relations:

Employees

Shareholders

Individual stakeholders3.63%
Mutual fund holders12.93%
Other institutional10.32%

Top Executives

Jack E. StoverPresident, Chief Executive Officer & Director
James EarlyChief Financial Officer
Rhonda De StefanoVice President & Associate General Counsel
Patrick K. KaneVice President & Controller
Steve RynkowskiVP-Learning, Development & Commercial Operations